Sunnyvale, CA — Molecular Devices today announced that European Patent Office (EPO) has upheld Molecular Devices foundational planar patch-clamp patent (EP No 1 040 349 B1). The board will issue a written decision to this effect in the near future. The ruling will be the final determination of the EPO and cannot be appealed. “Molecular […]

SAN DIEGO — Sequenom, Inc. (NASDAQ:SQNM) today announced that on May 3, 2010, following a hearing, the U.S. District Court for the Southern District of California entered an order approving the stipulation of settlement reached in the class action securities lawsuits consolidated under the caption In re Sequenom, Inc. Securities Litigation, Master File No. 3:09-cv-00921 […]

The Superior Court confirms that the directors of the Company have accomplished their duty with honesty and competency LONGUEUIL, QC /CNW Telbec/ – In a judgment rendered April 15 2010, Quebec Superior Court has dismissed all of Karol Brassard’s allegations and claims made in a lawsuit for oppressive behavior against Clemex Technologies Inc. and its […]

LEXINGTON, Mass. (USA), and HEIDELBERG, Germany -– febit announced today the receipt of an EU patent, #EP 1 728 860B1, for its technology to synthesize minimal genomes. The new patent protects febit’s technology for combining genes to construct a minimal functional genome or parts of it. The EU patent complements earlier patents on the synthesis […]

Puchheim, Germany / b3c newswire / – Sloning, leading supplier of synthetic biology tools was awarded US Patent No, 7,695,906. Sloning’s enabling platform technology – Slonomics® – allows researchers to increase the success rate of their screening for new and optimized therapeutic antibodies, proteins or industrial enzymes. Key to Sloning’s success is the company’s core […]

BALA CYNWYD, Pa.–Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Symyx Technologies, Inc. (“Symyx” or the “Company”) (Nasdaq:SMMX – News) relating to the proposed acquisition of Symyx by Accelrys, Inc. Under the terms of the agreement, Symyx shareholders would receive 0.7802 of Accelrys […]

DALLAS–Kendall Law Group is investigating Symyx Technologies, Inc. (NASDAQ:SMMX – News) for shareholders in connection to the proposed sale of the Company to Accelrys, Inc. Symyx shareholders, and anyone with knowledge of the transaction, are encouraged to contact the Kendall Law Group by email at hlindley@kendalllawgroup.com. The national securities litigation firm is investigating whether a […]

WOBURN, Mass.–SRU Biosystems, a leader in highly sensitive label-free detection technologies, today announced the issuance of a Notice of Allowance from the US Patent Office for claims on a fundamental patent application, US Patent Application No. 11/635,934, for performing cellular assays on optical label-free biosensors. The allowed material includes claims directed to methods for measuring […]

PITTSBURGH (ChemImage Corporation) — ChemImage Corporation announced today the receipt of its 100th U.S. patent, number 7,692,776 for a chemical imaging explosives optical sensor that detects explosive compounds. Over the past 16 years, ChemImage has invested substantial resources in building a robust patent portfolio which includes patents for chemical imaging instrumentation, image analysis, threat detection, […]

BENSALEM, Pa.–Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Symyx Technologies Inc. (“Symyx” or the “Company”) (NASDAQ:SMMX – News) related to the Company’s agreement to merge with Accelrys, Inc. (“Accelrys”) in a proposed all-stock transaction. Under the terms of the merger agreement entered into […]